Potentiation of the anticonvulsant effects of antiepileptic drugs by "nootropics"; a potential new therapeutic approach.
D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage*; D002220:Carbamazepine / Q000008:administration & dosage; D002998:Clonazepam / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy*; D010634:Phenobarbital / Q000008:administration & dosage; D010889:Piracetam / Q000008:administration & dosage*; D011760:Pyrrolidinones / Q000008:administration & dosage*; D051381:Rats; D014635:Valproic Acid / Q000008:administration & dosage; D014748:Vinca Alkaloids / Q000008:administration & dosage*; D014749:Vincamine / Q000008:administration & dosage*
D000927:Anticonvulsants; D011760:Pyrrolidinones; D014748:Vinca Alkaloids; D002220:Carbamazepine; D002998:Clonazepam; D014635:Valproic Acid; D014749:Vincamine; D010634:Phenobarbital; D010889:Piracetam